Anti-Human CD14 Recombinant Nanobody (SAA2077) (HY038033)

价格:

规格：

50ug
100ug
1mg

数量：

联系我们

一键复制产品信息

概述
图片
参考文献
产品说明书

概述

货号

HY038033

品牌

abinScience

描述

Anti-Human CD14 Nanobody (SAA2077) [SAA2077] (HY038033) is a alpaca monoclonal antibody detecting CD14 in ELISA. Suitable for Human.

种属反应性

Human

应用

ELISA

宿主

Alpaca

同种型

VHH-8His-Cys-tag

克隆号

SAA2077

克隆类型

Monoclonal

靶标

Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14

内毒素水平

Please contact with the lab for this information.

纯度

>95% as determined by SDS-PAGE.

纯化方式

Purified by Nickel column.

Accession号

P08571

状态

Liquid

保存溶液

0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

产品使用信息

应用方法	稀释比例
ELISA	1:2000-1:20000

稳定性和存储

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

背景

Monocyte differentiation antigen CD14 is a ~40 kDa protein. Coreceptor for bacterial lipopolysaccharide. In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway. Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-).

1. Wright, SD. et al. (1990) Science (New York, N.Y.) 249, 1431-3. PMID: 1698311

2. Kelley, SL. et al. (2013) Journal of immunology (Baltimore, Md. : 1950) 190, 1304-11. PMID: 23264655

3. Tsukamoto, H. et al. (2010) International immunology 22, 271-80. PMID: 20133493

4. Murakami, K. et al. (2012) FEBS letters 586, 319-24. PMID: 22265692

5. Haziot, A. et al. (1996) Immunity 4, 407-14. PMID: 8612135

6. Triantafilou, M. et al. (2006) The Journal of biological chemistry 281, 31002-11. PMID: 16880211

7. Estruch, M. et al. (2013) Atherosclerosis 229, 356-62. PMID: 23880187

Note

For research use only.

图片

SDS-PAGE

SDS-PAGE for Anti-Human CD14 Nanobody (SAA2077)

参考文献

产品说明书

Anti-Human CD14 Recombinant Nanobody (SAA2077).pdf

公式

质量 (g) = 浓度 (mol/L) × 体积 (L) × 分子量 (g/mol)

填写 质量、浓度、体积中的任意 2 项 + 分子量，自动计算未知值。

质量

浓度

体积

分子量 *

g/mol

公式

C₁ × V₁ = C₂ × V₂

填写 4 项中的任意 3 项，自动计算未知值。

母液

C₁ (起始浓度)

V₁ (起始体积)

工作液

C₂ (终浓度)

V₂ (终体积)

重组蛋白

抗体

试剂盒

实验相关试剂

Anti-Human CD14 Recombinant Nanobody (SAA2077) (HY038033)

概述

图片

参考文献

产品说明书

相关产品推荐

重组蛋白

抗体

试剂盒

实验相关试剂

Anti-Human CD14 Recombinant Nanobody (SAA2077) (HY038033)

概述

图片

参考文献

产品说明书

相关产品推荐

获取报价